CH546788A - Procede de preparation d'agents anti-inflammatoires. - Google Patents
Procede de preparation d'agents anti-inflammatoires.Info
- Publication number
- CH546788A CH546788A CH961272A CH546788DA CH546788A CH 546788 A CH546788 A CH 546788A CH 961272 A CH961272 A CH 961272A CH 546788D A CH546788D A CH 546788DA CH 546788 A CH546788 A CH 546788A
- Authority
- CH
- Switzerland
- Prior art keywords
- inflammatory agents
- preparing anti
- preparing
- inflammatory
- agents
- Prior art date
Links
- 229940121363 anti-inflammatory agent Drugs 0.000 title 1
- 239000002260 anti-inflammatory agent Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/38—[b, e]-condensed with two six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
- C07D279/22—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15767871A | 1971-06-28 | 1971-06-28 | |
CA143149 | 1972-05-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
CH546788A true CH546788A (fr) | 1974-03-15 |
Family
ID=25667058
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH961272A CH546788A (fr) | 1971-06-28 | 1972-06-27 | Procede de preparation d'agents anti-inflammatoires. |
Country Status (5)
Country | Link |
---|---|
US (1) | US3767653A (enrdf_load_stackoverflow) |
CH (1) | CH546788A (enrdf_load_stackoverflow) |
DE (1) | DE2230592A1 (enrdf_load_stackoverflow) |
FR (1) | FR2147960B1 (enrdf_load_stackoverflow) |
GB (1) | GB1388054A (enrdf_load_stackoverflow) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4079135A (en) * | 1973-12-13 | 1978-03-14 | Imperial Chemical Industries Limited | Morpholine derivatives as antidepressants |
US4033951A (en) * | 1973-12-13 | 1977-07-05 | Imperial Chemical Industries Limited | Morpholine derivative of a 1,4-benzothiazin-3-one |
US4006161A (en) * | 1973-12-26 | 1977-02-01 | Eli Lilly And Company | Thio-substituted 2-oxo-indolines |
JPS5121827A (en) * | 1974-08-14 | 1976-02-21 | Fuji Photo Film Co Ltd | Shashinyokapuraa |
US4268301A (en) * | 1978-04-17 | 1981-05-19 | Sumitomo Chemical Company, Limited | 1,4-Benzothiazines |
AU566869B2 (en) * | 1982-05-11 | 1987-11-05 | Imperial Chemical Industries Plc | Spiro (imidazolidine-4,3'-indoline) 2,2',5-triones |
ATE41420T1 (de) * | 1984-02-07 | 1989-04-15 | Pfizer | 1,3-disubstituierte 2-oxindole und deren anwendung als analgetische und antiinflammatorische mittel. |
IE57741B1 (en) * | 1984-03-19 | 1993-03-24 | Pfizer | Process for making 2-oxindole-1-carboxamides and intermediates therefor |
US4556672A (en) * | 1984-03-19 | 1985-12-03 | Pfizer Inc. | 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents |
US4690943A (en) * | 1984-09-19 | 1987-09-01 | Pfizer Inc. | Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds |
US4808601A (en) * | 1984-09-19 | 1989-02-28 | Pfizer Inc. | Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds |
US4752609A (en) * | 1985-06-20 | 1988-06-21 | Pfizer Inc. | Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds |
DE3545097A1 (de) * | 1985-12-19 | 1987-07-02 | Bayer Ag | 1-h-pyrido-(3,2-b)(1,4)-thiazine |
US5036099A (en) * | 1987-02-02 | 1991-07-30 | Pfizer Inc. | Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide |
EP2886541A1 (en) * | 2013-12-19 | 2015-06-24 | Sanofi | Oxindole derivatives, preparation thereof and therapeutic use in the treatment of AMPK-related diseases |
US10906899B2 (en) | 2016-05-10 | 2021-02-02 | Georgia State University Research Foundation, Inc. | Bicyclic fused pyrazole derivatives for the treatment of RSV |
CN109641042B (zh) | 2016-05-10 | 2023-06-09 | 乔治亚州立大学研究基金会股份有限公司 | 用于治疗rsv的杂环衍生物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3471481A (en) * | 1966-03-28 | 1969-10-07 | Squibb & Sons Inc | Benzothiazines |
-
1971
- 1971-06-28 US US00157678A patent/US3767653A/en not_active Expired - Lifetime
-
1972
- 1972-06-05 GB GB2609972A patent/GB1388054A/en not_active Expired
- 1972-06-22 DE DE2230592A patent/DE2230592A1/de active Pending
- 1972-06-27 CH CH961272A patent/CH546788A/fr not_active IP Right Cessation
- 1972-06-28 FR FR7223399A patent/FR2147960B1/fr not_active Expired
Also Published As
Publication number | Publication date |
---|---|
DE2230592A1 (de) | 1973-01-11 |
FR2147960B1 (enrdf_load_stackoverflow) | 1976-03-05 |
GB1388054A (en) | 1975-03-19 |
FR2147960A1 (enrdf_load_stackoverflow) | 1973-03-11 |
US3767653A (en) | 1973-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE763529A (fr) | Procede de preparation d'allophanate-polyisocyanates | |
CH552610A (fr) | Procede de preparation d'azapurinones. | |
BE768485A (fr) | Procede de preparation d'aryloxy-1,1,2,2-tetrafluoro-ethanes | |
BE784222A (fr) | Procede de preparation d'extraits de houblon | |
CH555316A (fr) | Procede de preparation d'aminocycloalcenylo-cyclohexenols. | |
CH546788A (fr) | Procede de preparation d'agents anti-inflammatoires. | |
CH551371A (fr) | Procede de preparation de composes d'amino-alcanols. | |
BE786840A (fr) | Procede de preparation de 1,2,4-triazine -5-ones | |
BE786518A (fr) | Procede de preparation d'oxa-bicyclo-alcenes | |
CH554319A (fr) | Procede de preparation d'aryl-guanidines ortho-disubstituees. | |
BE785344A (fr) | Procede de preparation d'alcenyl-silanes | |
CH550187A (fr) | Procede de preparation de l'eburnamonine. | |
BE777068A (fr) | Procede de preparation d'alcoylphenols | |
BE788171A (fr) | Procede de preparation d'alcoyl-tetralines | |
BE777067A (fr) | Procede de preparation d'alcoylphenols | |
BE761304A (fr) | Procede de preparation d'aminophenyl-trial-coxy-silanes | |
BE790056A (fr) | Procede de preparation de 1, 1'-dianthraquinonyles | |
CH550195A (fr) | Procede de preparation de derives d'isoxazolopyridinecetones. | |
BE804528A (fr) | Procede de preparation de trans-chrysanthemates d'almyle | |
BE803370A (fr) | Procede de preparation d'amino-anthraquinones | |
BE799198A (fr) | Procede de preparation d'amindazetidinones, | |
BE792804A (fr) | Procede de preparation d'hydroxocobalticorrinoide | |
BE781275A (fr) | Procede de preparation d'o-aminobenzonitriles | |
BE783223A (fr) | Procede de preparation d'agents antibacteriens | |
BE804619A (fr) | Procede de preparation d'halophenoxynitrobenzoates |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |